Catheter Precision, Inc. — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
Cathayer Precision's board designated a new Series C-4 Convertible Preferred Stock series on July 27, 2026, authorizing up to 80,000 shares with a stated value of $1,000 per share ($80 million aggregate) and a fixed conversion price of $0.35 per common share. The preferred stock has liquidation preference senior to common stock, conversion rights at holder option, and dividend rights. Holders obtain 4.99% beneficial ownership limitations (adjustable to 9.99%), anti-dilution protections, and broad veto rights over material corporate actions unless 33.33% of preferred stock remains outstanding.
Why this rating
Up to $80M preferred issuance vs. $3.9M market cap = ~20× company size; senior liquidation preference, heavy holder control covenants, and forced conversion mechanics impose severe dilution and governance constraints on tiny publicly traded company.
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.